Subcutaneous Tumor Xenograft
- Brain (U87-MG, U251)
- Breast (MCF-7, MDA-MB-231, MDA-MB-453, SK-BR-3)
- Bladder (T24, 5637, TCCSUP, HT-1376)
- Colon (HT29, HCT116, DLD1, SW480, COLO-205, LOVO)
- Epidermoid (A431)
- Gastric (N-87)
- Head & Neck (CAL-27, HEp-2)
- Lung (A549, H1975, NCI-H460, NCI-H441, NCI-H23, PC-9)
- Liver (HepG2)
- Melanoma (A375)
- Multiple myeloma (NCI-H929)
- Kidney (ACHN)
- Pancreas (BX-PC3, MIA PaCa-2)
- Prostate (DU145, PC-3)
- Ovary (SKOV-3, PA-1, OVCAR-3, OVCAR-5)
- Osteosarcoma (SJSA-1)
- Retinoblastoma (Y79, NCC-RbC-51)
- Medulloblastoma (D283)
Orthotopic Xenograft model
- Breast (MDA-MB-231)
- Colon (HT29, HCT-116)
- Lung (A549, PC-9)
- Pancreas (BxPC-3, MIA PaCa-2)
- Bladder (T24, UMC-1, RT-112)
- Brain (U87MG)
Syngeneic models
- B16F10 (Melanoma)
- LLC (Lewis lung carcinoma)
- 4T1, E3 (Breast tumor model)
- CT26, MC-38 (Colon carcinoma)
- NBT-II (Bladder carcinoma)
Metastasis models
- CML (K562)
- Murine melanoma(B16F10)
- Lung metastasis (A549, PC-9)
Leukemia models
- CML (K562)
- HEL
- AML (KG-1, Kausmi-3)
Human Primary Tissue Xenograft models
- Head and neck
- Breast cancer
Humanized model (huNOG-EXL)
- Prostate (PC-3)
- Under validation for other
- Cancer types
- Lung cancer
- Melanoma
- Colon cancer
